Stockscreener 앱 받기
37.55
4.28%
-1.68
시장 영업 전:
37.59
0.04
+0.11%
Tg Therapeutics Inc 주식(TGTX)의 최신 뉴스
Smartleaf Asset Management LLC Has $60,000 Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
TG Therapeutics (NasdaqCM:TGTX) Surges 28% Following US$23 Million Net Income Turnaround - Yahoo Finance
Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio? - Benzinga
Bank of New York Mellon Corp Increases Stake in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
Q2 Earnings Forecast for TG Therapeutics Issued By B. Riley - Defense World
TGTX Surges on Strong Q4 Results and Briumvi Success - GuruFocus.com
Why TG Therapeutics Stock Was Soaring This Week - Nasdaq
Why TG Therapeutics Shares Are Soaring Now - TipRanks
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week - MSN
TG Therapeutics Announces Schedule of Data Presentations - GlobeNewswire
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting - Yahoo Finance
Q1 Earnings Forecast for TG Therapeutics Issued By B. Riley - Defense World
This Biotech Stock Hits Buy Point After Earnings Burst - MSN
HC Wainwright Reaffirms “Buy” Rating for TG Therapeutics (NASDAQ:TGTX) - Defense World
TG Therapeutics FY2025 EPS Estimate Boosted by HC Wainwright - Defense World
Why TG Therapeutics, Inc. (TGTX) Surged On Monday? - MSN
TG Therapeutics, Inc. (NASDAQ:TGTX) Holdings Decreased by Private Advisor Group LLC - Defense World
TG Therapeutics (NASDAQ:TGTX) Upgraded by StockNews.com to Hold Rating - Defense World
TG Therapeutics (NASDAQ:TGTX) Shares Up 5.2% After Earnings Beat - Defense World
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2024 Earnings Call Transcript - MSN
TG Therapeutics Target of Unusually Large Options Trading (NASDAQ:TGTX) - Defense World
TG Therapeutics, A New Leaderboard Stock, Skyrockets 17% On Sales Beat, Bullish Guide - MSN
TG Therapeutics stock soars to 52-week high of $36.89 By Investing.com - Investing.com South Africa
TG Therapeutics stock soars to 52-week high of $36.89 - Investing.com India
Cautious Outlook on TG Therapeutics Amid Competitive Pressures and Overvaluation Concerns - TipRanks
B. Riley Raises Price Target on TG Therapeutics to $53 From $38, Keeps Buy Rating -March 04, 2025 at 08:05 am EST - Marketscreener.com
H.C. Wainwright maintains TG Therapeutics stock Buy rating, $55 target - Investing.com India
H.C. Wainwright maintains TG Therapeutics stock Buy rating, $55 target By Investing.com - Investing.com UK
Strong Financial Performance and Promising Outlook Drive Buy Rating for TG Therapeutics - TipRanks
TG Therapeutics stock soars on Overweight rating at Cantor By Investing.com - Investing.com Canada
Exploring 3 High Growth Tech Stocks In The US Market - Yahoo Finance
Company News for Mar 4, 2025 - Yahoo Finance
TG Therapeutics Inc (TGTX) Q4 2024 Earnings Call Highlights: Strong U.S. ... - Yahoo Finance
TG Therapeutics (NASDAQ:TGTX) Sees Large Volume Increase on Better-Than-Expected Earnings - Defense World
TG Therapeutics Reports Strong 2024 Financial Results and Outlook - TipRanks
TG Therapeutics Earnings Call: Strong Growth Amid Challenges - TipRanks
TG Therapeutics: Q4 Earnings Snapshot - CTPost
TG Therapeutics stock spikes on strong financials and optimism for its flagship drug - Mugglehead
TG Therapeutics soared 17% after earnings surprise - MSN
TG Therapeutics targets $525M BRIUMVI revenue in 2025 while advancing subcutaneous formulation and pivotal trials - MSN
Why This New Leaderboard Stock Just Skyrocketed 14% - Investor's Business Daily
TG Therapeutics: A Wonderful Hold (NASDAQ:TGTX) - Seeking Alpha
TG Therapeutics stock soars on Overweight rating at Cantor - Investing.com India
TG Therapeutics reports Q4 EPS 15c, consensus 17c - TipRanks
Earnings call transcript: TG Therapeutics Q4 2024 earnings beat forecasts By Investing.com - Investing.com Canada
Earnings call transcript: TG Therapeutics Q4 2024 earnings beat forecasts - Investing.com India
TG Therapeutics Soars Nearly 18% as Strong Q4 Results Fuel Growth Optimism - Yahoo Finance
TG Therapeutics: A Biotech Stock on the Rise, But What’s Behind Its Recent Surge? - RagingBull
TG Therapeutics (NasdaqCM:TGTX) Reports US$108M Revenue For Q4 2024 With Net Income Of US$23M - Yahoo Finance
TG Therapeutics Shares Rise After Reporting Q4 Results -March 03, 2025 at 11:58 am EST - Marketscreener.com
TG Therapeutics rises on quarterly net product revenue beat - TradingView
TG Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
TG Therapeutics stock rises following upbeat Q4 earnings By Investing.com - Investing.com Canada
TG Therapeutics stock rises following upbeat Q4 earnings - Investing.com
TG Therapeutics Stock Rockets As Surprise Profit Smashes Views By 157% - MSN
2.14%
2.83%
자본화:
|
볼륨(24시간):